Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00335140 · BASELINE

Baseline characteristics

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma · Source last updated 2023-07-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      25
    units
    Participants
groups
  1. description
    rituximab cytarabine dexamethasone leucovorin calcium methotrexate procarbazine hydrochloride vincristine sulfate
    id
    BG000
    title
    Rituximab + Standard Chemotherapy
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          15
        title
        Age < 60 years
      2. measurements
        1. group Id
          BG000
          value
          10
        title
        Age ≥ 60 years
      title
      Age
    description
    Older or younger than 60
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          15
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          10
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          24
        title
        White
      2. measurements
        1. group Id
          BG000
          value
          1
        title
        Asian
      title
      Race
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          25
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        title
        0
      2. measurements
        1. group Id
          BG000
          value
          15
        title
        1
      3. measurements
        1. group Id
          BG000
          value
          5
        title
        2
      4. measurements
        1. group Id
          BG000
          value
          4
        title
        3
    description
    0 = Fully active, able to carry on all pre-disease performance without restriction 1. = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2. = Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours 3. = Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours 4. = Completely disabled; cannot carry on any selfcare; totally confined to bed or chair
    param Type
    COUNT_OF_PARTICIPANTS
    title
    ECOG Performance Status
    unit Of Measure
    Participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        No symptoms
      2. measurements
        1. group Id
          BG000
          value
          11
        title
        Minor symptoms
      3. measurements
        1. group Id
          BG000
          value
          5
        title
        Moderate symptoms/fully active
      4. measurements
        1. group Id
          BG000
          value
          7
        title
        Moderate symptoms/less than fully active
      5. measurements
        1. group Id
          BG000
          value
          2
        title
        Severe neurologic symptoms
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Neurologic Function Status
    unit Of Measure
    Participants
  7. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          21
        title
        Never
      2. measurements
        1. group Id
          BG000
          value
          4
        title
        Symptomatic or on medication
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Cerebrovascular Disease
    unit Of Measure
    Participants
  8. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          9
        title
        Never
      2. measurements
        1. group Id
          BG000
          value
          7
        title
        Symptomatic or on medication
      3. measurements
        1. group Id
          BG000
          value
          7
        title
        Past history of
      4. measurements
        1. group Id
          BG000
          value
          2
        title
        Missing/unknown
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Other Medical Problems at Baseline
    unit Of Measure
    Participants
population Description
Eligible patients who began protocol therapy
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      25
    units
    Participants
groups
  1. description
    rituximab cytarabine dexamethasone leucovorin calcium methotrexate procarbazine hydrochloride vincristine sulfate
    id
    BG000
    title
    Rituximab + Standard Chemotherapy
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          15
        title
        Age < 60 years
      2. measurements
        1. group Id
          BG000
          value
          10
        title
        Age ≥ 60 years
      title
      Age
    description
    Older or younger than 60
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          15
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          10
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          24
        title
        White
      2. measurements
        1. group Id
          BG000
          value
          1
        title
        Asian
      title
      Race
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          25
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        title
        0
      2. measurements
        1. group Id
          BG000
          value
          15
        title
        1
      3. measurements
        1. group Id
          BG000
          value
          5
        title
        2
      4. measurements
        1. group Id
          BG000
          value
          4
        title
        3
    description
    0 = Fully active, able to carry on all pre-disease performance without restriction 1. = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2. = Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours 3. = Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours 4. = Completely disabled; cannot carry on any selfcare; totally confined to bed or chair
    param Type
    COUNT_OF_PARTICIPANTS
    title
    ECOG Performance Status
    unit Of Measure
    Participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        No symptoms
      2. measurements
        1. group Id
          BG000
          value
          11
        title
        Minor symptoms
      3. measurements
        1. group Id
          BG000
          value
          5
        title
        Moderate symptoms/fully active
      4. measurements
        1. group Id
          BG000
          value
          7
        title
        Moderate symptoms/less than fully active
      5. measurements
        1. group Id
          BG000
          value
          2
        title
        Severe neurologic symptoms
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Neurologic Function Status
    unit Of Measure
    Participants
  7. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          21
        title
        Never
      2. measurements
        1. group Id
          BG000
          value
          4
        title
        Symptomatic or on medication
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Cerebrovascular Disease
    unit Of Measure
    Participants
  8. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          9
        title
        Never
      2. measurements
        1. group Id
          BG000
          value
          7
        title
        Symptomatic or on medication
      3. measurements
        1. group Id
          BG000
          value
          7
        title
        Past history of
      4. measurements
        1. group Id
          BG000
          value
          2
        title
        Missing/unknown
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Other Medical Problems at Baseline
    unit Of Measure
    Participants
population Description
Eligible patients who began protocol therapy

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice